More News
-
-
BioNTech and Fosun Pharma Announce Full Regulatory Approval of their Mono- and Bivalent COVID-19 Vaccine COMIRNATY® in Individuals 12 Years and Older in Hong Kong
2022-12-23COMIRNATY® Original/Omicron BA.4/BA.5 is the first and currently only variant-adapted vaccine available for individuals 12 years and older which was granted a Biologics License Application equivalent in Hong KongIndividuals 12 years and older can now receive COMIRNATY® vaccines at medical institutions or clinics in Hong Kong with a medical prescription, in add
-
-
Fosun International Granted Three Awards from Global Banking and Finance Review in the United Kingdom
2022-12-23On 23 December 2022, Fosun International was notified by Global Banking and Finance Review, a famous financial magazine in the United Kingdom, that Fosun International was granted three awards, namely “Brand of the Year Awards - Holding Group Brand of the Year Awards Asia 2022”, “ESG & Sustainability Awards - Best Sustainable Development Company Asia 2022”
-
-
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
2022-12-22Approximately 11,500 of the companies’ mRNA-based COVID-19 vaccine doses arrived on the Chinese Mainland to enable vaccination campaign for German expatriates.Vaccines expected to be available in Beijing, Shanghai, Guangzhou, Shenyang and Chengdu.MAINZ, GERMANY, and SHANGHAI, CHINA, December 22, 2022 — BioNTech SE (Nasdaq: BNTX,
-
-
Lanvin Group Debuts on NYSE under Ticker “LANV”
2022-12-16December 15, 2022 – Lanvin Group (the “Group”), a global luxury fashion group, and Primavera Capital Acquisition Corporation (NYSE: PV) (“PCAC”), today announced the completion of their business combination and the listing of the shares and warrants of Lanvin Group Holdings Limited (“LGHL”) under the new ticker symbols “LANV” and “LANV
-
-
Corporate Governance Asia’s CEOs Interview - Fosun’s Thirty Years of Establishment: Focusing on Core Businesses, Deepening Innovation and Globalization
2022-12-16(16 December 2022) The most authoritative corporate governance magazine in the Asia Pacific region, Corporate Governance Asia, has recently conducted an interview with Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International. The article was recently published with the headline of “Fosun’s Thirty Years of Establishment: Focusing on Core B